Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Markkleeberg

19 clinical trials in Markkleeberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Markkleeberg at a glance
19
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

19 trials in Markkleeberg

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:OMECAMTIV MECARBIL
  • Sponsor:Cytokinetics Inc.

Obesity+1

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Obesity

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Markkleeberg

What the registry says about research in the country

01 Cardiovascular Prevention

Innovative research focusing on heart failure prevention through combination therapy approaches. Clinical investigations aim to reduce cardiovascular mortality and improve patient outcomes.

  • Heart Failure Prevention
  • Cardiovascular Death Risk Reduction
  • Combination Therapy Assessment

Studies evaluate the effectiveness of novel therapeutic combinations in preventing heart failure events.

02 Stroke Prevention

Advanced research in atrial fibrillation management, exploring new therapeutic options for stroke prevention. Studies compare novel anticoagulation approaches with established treatments.

  • Atrial Fibrillation Management
  • Stroke Prevention Strategies
  • Systemic Embolism Prevention

Trials focus on developing safer and more effective treatments for patients with irregular heartbeat.

03 Lipid Management

Comprehensive studies addressing hypercholesterolemia and severe hypertriglyceridemia. Research evaluates innovative treatments for managing blood lipid levels.

  • Cholesterol Level Management
  • Triglyceride Reduction
  • Comparative Treatment Efficacy

Investigations aim to optimize lipid-lowering therapies and improve cardiovascular health outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.